Hepatitis C: prevalence and common genotypes among ethnic groups in Jeddah, Saudi Arabia

M Fakeeh1, A M Zaki

  • 1Internal Medicine Department, Dr Soliman Fakeeh Hospital, Jeddah, Saudi Arabia.

Insights

Hepatitis C virus (HCV) antibody prevalence was 6.75% overall in Jeddah, Saudi Arabia. Egyptians had the highest HCV infection rate (22.54%), with genotype 4 being predominant in both Egyptians and Saudis.

Area of Science:

  • Virology
  • Epidemiology
  • Public Health

Background:

  • Hepatitis C virus (HCV) poses a significant global health challenge.
  • Understanding HCV prevalence and genotypes is crucial for effective control strategies.
  • Previous data on HCV epidemiology in Saudi Arabia and surrounding regions were limited.

Purpose of the Study:

  • To determine the prevalence of antibodies to Hepatitis C virus (HCV) in a diverse patient population in Jeddah, Saudi Arabia.
  • To identify the distribution of different HCV genotypes within the studied population.
  • To compare HCV prevalence across different nationalities and patient groups.

Main Methods:

  • A cross-sectional study was conducted involving 3,350 serum samples.
  • Samples were collected from outpatient clinics, preoperative patients, and antenatal care attendees between January and September 1998.
  • Third-generation ELISA was used for antibody detection, and genotyping was performed on positive samples.

Main Results:

  • The overall prevalence of HCV antibodies was 6.75%.
  • Prevalence varied significantly by nationality: Egyptians (22.54%), Saudis (5.87%), Yemenis (2.12%), and other Middle Eastern/Asian countries (3.38%-4.98%).
  • In Saudi Arabia, HCV genotype 4 (45.9%) and 1a (40.6%) were most common. In Egypt, genotype 4 was highly prevalent (91.6%).

Conclusions:

  • HCV infection represents a considerable public health issue in Jeddah, with notable variations in prevalence among different nationalities.
  • Genotype 4 is the predominant HCV type among Egyptians and a significant type among Saudis in this region.
  • Targeted screening and intervention strategies may be necessary, considering the high prevalence in specific ethnic groups like Egyptians.

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...